ARUP's Laboratory Test Directory

Beta-hCG, Serum Quantitative Tumor Marker : 0070029

Mnemonic: BHCG TM

Methodology: Chemiluminescent Immunoassay
Performed: Sun-Sat
Reported: Within 24 hours
Specimen Required: Collect:  One 4 mL serum separator tube. 

Transport:  1 mL serum at 2-8°C. (Min: 0.4 mL)  Submit specimen in an ARUP Standard Transport Tube.

Pediatric Collection/Transport:  0.4 mL serum at 2-8°C.

Remarks:  Allow specimen to clot completely at room temperature.  Separate serum from cells ASAP.

Stability:  After separation from cells: Ambient: 8 hours; Refrigerated: 1 week; Frozen: 2 months
Reference Interval:
Male: 0-3 IU/L
Female: 0-5 IU/L
Interpretive Data: The Siemens Immulite® 2000 HCG chemiluminescent immunoassay is used. Results obtained with different assay methods or kits cannot be used interchangeably.  Human chorionic gonadotropin (hCG) is a valuable aid in the management of patients with trophoblastic tumors, nonseminomatous testicular tumors, and seminomas when used in conjunction with information available from the clinical evaluation and other diagnostic procedures. Increased serum hCG concentrations have also been observed in melanoma, carcinomas of the breast, gastrointestinal tract, lung, and ovaries, and in benign conditions, including cirrhosis, duodenal ulcer, and inflammatory bowel disease.  This result cannot be interpreted as absolute evidence of the presence or absence of malignant disease.  This result is not interpretable as a tumor marker in pregnant females.  This assay is FDA cleared for use in the detection of pregnancy, but is not labeled for use as a tumor marker.
CPT Code(s): 84702
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org